Cellular hypersensitivity to neocarzinostatin in ataxia-telangiectasia skin fibroblasts
Related Experiment Videos
Abstract:
Cellular sensitivity of human skin fibroblast strains from three healthy donors, eight ataxia-telangiectasia (A-T) patients belonging to six sibships, and two A-T heterozygotes to the lethal action of the antitumor antibiotic neocarzinostatin was tested, using colony-forming ability as the criterion for survival. All the A-T strains were significantly more sensitive to killing by neocarzinostatin than were the control strains. The average D0 for the A-T strains following neocarzinostatin treatment was 14.6 ng/ml, as compared to 37.9 ng/ml for the normal strains. The two A-T heterozygous strains showed intermediate sensitivity with an average D0 of 26.9 ng/ml. Neocarzinostatin sensitivity of A-T cells could therefore serve as a convenient aid for the laboratory diagnosis of A-T. Since A-T cells are also known to be hypersensitive to ionizing radiation and bleomycin, it would appear that they are primarily hypersensitive to DNA-breaking agents.
Insights
Ataxia-telangiectasia (A-T) cells show increased sensitivity to the antitumor antibiotic neocarzinostatin. This heightened sensitivity can aid in the laboratory diagnosis of A-T and suggests A-T cells are sensitive to DNA-breaking agents.
Area of Science:
- Oncology
- Genetics
- Cell Biology
Background:
- Ataxia-telangiectasia (A-T) is a rare genetic disorder affecting multiple systems.
- A-T cells are known to be hypersensitive to DNA-damaging agents like ionizing radiation and bleomycin.
Purpose of the Study:
- To investigate the cellular sensitivity of Ataxia-Telangiectasia (A-T) patient fibroblast strains to neocarzinostatin.
- To evaluate the potential of neocarzinostatin sensitivity as a diagnostic marker for A-T.
Main Methods:
- Human skin fibroblast strains from healthy donors, A-T patients, and A-T heterozygotes were used.
- Colony-forming ability was assessed to determine cell survival after neocarzinostatin treatment.
- Neocarzinostatin sensitivity was quantified using the D0 value (average dose for 37% survival).
Main Results:
- All A-T fibroblast strains exhibited significantly higher sensitivity to neocarzinostatin compared to normal control strains.
- The average D0 for A-T strains was 14.6 ng/ml, compared to 37.9 ng/ml for normal strains.
- A-T heterozygous strains displayed intermediate sensitivity with an average D0 of 26.9 ng/ml.
Conclusions:
- Neocarzinostatin sensitivity in A-T cells can serve as a practical laboratory diagnostic aid for Ataxia-Telangiectasia.
- The findings support the hypothesis that A-T cells are generally hypersensitive to DNA-breaking agents.